• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Longeveron Inc (NQ: LGVN )

2.090 -0.070 (-3.24%)
Streaming Delayed Price Updated: 2:49 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
October 28, 2024
Via Benzinga
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present ‘Important’ Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer’s Disease Conference
October 14, 2024
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
October 09, 2024
Via Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) CEO to Participate in Fireside Cat at UBS Virtual Organ Restoration and Cell Therapy Day
October 07, 2024
Via Investor Brand Network
Beyond The Numbers: 4 Analysts Discuss Longeveron Stock
August 27, 2024
Via Benzinga
Longeveron (LGVN) Stock Pops on Phase 2 Trial Updates
July 29, 2024
The good news on Lomecel-B comes at an opportune time for Longeveron and LGVN stock -- it could attract a buyer. 
Via InvestorPlace
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa
September 26, 2024
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces Alignment with FDA on Development Pathway for Lomecel-B(TM) in HLHS
September 03, 2024
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces Participation at H.C. Wainwright 26th Annual Global Investment Conference
August 27, 2024
Via Investor Brand Network
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Reports on Q2 2024 Financial Results, Business Highlights
August 15, 2024
Via Investor Brand Network
Exposures Product Safety
(LGVN) - Analyzing Longeveron's Short Interest
July 24, 2024
Via Benzinga
LGVN Stock Earnings: Longeveron Misses EPS, Beats Revenue for Q2 2024
August 14, 2024
LGVN stock results show that Longeveron missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference Call
August 06, 2024
Via Investor Brand Network
Exposures Product Safety
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?
August 01, 2024
A look at the most-searched tickers on Benzinga Pro for the month of July shows some familiar names like Tesla, Nvidia and Apple. Here's a look at the others. 
Via Benzinga
The Top 3 Small-Cap Stocks to Buy Now: Summer 2024
August 01, 2024
Small-cap stocks are on the rise once again as the Federal Reserve ponders cutting interest rates, which has held back the sector. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 29, 2024
Via Benzinga
Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?
July 29, 2024
Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report. 
Via InvestorPlace
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Lomecel-B(TM) Study Results Presented at the Alzheimer’s Association International Conference
July 29, 2024
Via Investor Brand Network
Exposures Product Safety
Why Is Alzheimer's-Focused Longeveron Stock Trading Higher On Monday?
July 29, 2024
Longeveron presented promising Phase 2a clinical trial data for Lomecel-B at the AAIC 2024. The trial showed the drug's safety and efficacy in treating Alzheimer's, demonstrating slowed disease... 
Via Benzinga
Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
July 29, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 29, 2024
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning! 
Via InvestorPlace
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
July 29, 2024
Via Benzinga
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Closes on $9M Registered Direct Offering
July 22, 2024
Via Investor Brand Network
Exposures Product Safety
5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK
July 19, 2024
Via AB Newswire
Exposures Product Safety
Why Longeveron (LGVN) Shares Are Down 15%
July 18, 2024
Longeveron shares are trading lower by 15.9% during Thursday's session. The company announced a $9.0 million registered direct offering of 2.2 million shares of its common stock. 
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 18, 2024
Via Benzinga
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Expands Growing Telecommunications Sector Through New Subsidiary
July 18, 2024
Via Investor Brand Network
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Enters into $9M Registered Direct Offering
July 18, 2024
Via Investor Brand Network
Exposures Product Safety
ACHR Stock Alert: Archer Receives Funding to Expand Manufacturing Facility
July 17, 2024
Archer Aviation stock is down on Wednesday as ACHR investors appear unimpressed by plans to expand its manufacturing facility. 
Via InvestorPlace
InvestorNewsBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Lomecel-B(TM) Granted Fast Track Designation for Treatment of Mild Alzheimer’s Disease
July 17, 2024
Via Investor Brand Network
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap